Deal Making
Featured on Deal Making
Industry consortium takes aim at lowering CGT production costs
Deal-MakingIndustry consortium takes aim at lowering CGT production costsIndustry consortium takes aim at lowering CGT production costs
GSK, Cytiva, and Lonza are among 20 companies looking to develop technologies aimed at lowering the cost of cell and gene therapy production.
More from Deal Making
Subscribe to receive our monthly print or digital publication
Join our 70,000+ readers. And yes, it's completely free.